Literature DB >> 19822144

Brain gangliosides in axon-myelin stability and axon regeneration.

Ronald L Schnaar1.   

Abstract

Gangliosides, sialic acid-bearing glycosphingolipids, are expressed at high abundance and complexity in the brain. Altered ganglioside expression results in neural disorders, including seizures and axon degeneration. Brain gangliosides function, in part, by interacting with a ganglioside-binding lectin, myelin-associated glycoprotein (MAG). MAG, on the innermost wrap of the myelin sheath, binds to gangliosides GD1a and GT1b on axons. MAG-ganglioside binding ensures optimal axon-myelin cell-cell interactions, enhances long-term axon-myelin stability and inhibits axon outgrowth after injury. Knowledge of the molecular interactions of brain gangliosides may improve understanding of axon-myelin stability and provide opportunities to enhance recovery after nerve injury. Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822144      PMCID: PMC2856809          DOI: 10.1016/j.febslet.2009.10.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  53 in total

Review 1.  Human myelination and perinatal white matter disorders.

Authors:  Hannah C Kinney
Journal:  J Neurol Sci       Date:  2004-12-19       Impact factor: 3.181

2.  The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.

Authors:  Karthik Venkatesh; Onanong Chivatakarn; Hakjoo Lee; Pushkar S Joshi; David B Kantor; Barbara A Newman; Rose Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

3.  Asymmetric membrane ganglioside sialidase activity specifies axonal fate.

Authors:  Jorge Santos Da Silva; Takafumi Hasegawa; Taeko Miyagi; Carlos G Dotti; Jose Abad-Rodriguez
Journal:  Nat Neurosci       Date:  2005-04-17       Impact factor: 24.884

4.  Sialidase enhances spinal axon outgrowth in vivo.

Authors:  Lynda J S Yang; Ileana Lorenzini; Katarina Vajn; Andrea Mountney; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

Review 5.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

6.  Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.

Authors:  Tadashi Yamashita; Yun-Ping Wu; Roger Sandhoff; Norbert Werth; Hiroki Mizukami; Jessica M Ellis; Jeffrey L Dupree; Rudolf Geyer; Konrad Sandhoff; Richard L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

7.  Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.

Authors:  Baohan Pan; Susan E Fromholt; Ellen J Hess; Thomas O Crawford; John W Griffin; Kazim A Sheikh; Ronald L Schnaar
Journal:  Exp Neurol       Date:  2005-09       Impact factor: 5.330

8.  Potent glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth in vitro.

Authors:  Alka A Vyas; Ola Blixt; James C Paulson; Ronald L Schnaar
Journal:  J Biol Chem       Date:  2005-02-08       Impact factor: 5.157

9.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder.

Authors:  Y Liu; R Wada; H Kawai; K Sango; C Deng; T Tai; M P McDonald; K Araujo; J N Crawley; U Bierfreund; K Sandhoff; K Suzuki; R L Proia
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains.

Authors:  K Kasahara; Y Watanabe; T Yamamoto; Y Sanai
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

View more
  58 in total

1.  Single cell ganglioside catabolism in primary cerebellar neurons and glia.

Authors:  David C Essaka; Jillian Prendergast; Richard B Keithley; Ole Hindsgaul; Monica M Palcic; Ronald L Schnaar; Norman J Dovichi
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

2.  A mouse model of blast-induced mild traumatic brain injury.

Authors:  Vardit Rubovitch; Meital Ten-Bosch; Ofer Zohar; Catherine R Harrison; Catherine Tempel-Brami; Elliot Stein; Barry J Hoffer; Carey D Balaban; Shaul Schreiber; Wen-Ta Chiu; Chaim G Pick
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

3.  Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.

Authors:  Carolina Gil-Tommee; Guadalupe Vidal-Martinez; C Annette Reyes; Javier Vargas-Medrano; Gloria V Herrera; Silver M Martin; Stephanie A Chaparro; Ruth G Perez
Journal:  Exp Neurol       Date:  2018-10-25       Impact factor: 5.330

4.  Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid.

Authors:  Adnan Halim; Gunnar Brinkmalm; Ulla Rüetschi; Ann Westman-Brinkmalm; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Göran Larson; Jonas Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-28       Impact factor: 11.205

5.  Sialylation regulates brain structure and function.

Authors:  Seung-Wan Yoo; Mary G Motari; Keiichiro Susuki; Jillian Prendergast; Andrea Mountney; Andres Hurtado; Ronald L Schnaar
Journal:  FASEB J       Date:  2015-04-06       Impact factor: 5.191

6.  Biosynthesis of the major brain gangliosides GD1a and GT1b.

Authors:  Elizabeth R Sturgill; Kazuhiro Aoki; Pablo H H Lopez; Daniel Colacurcio; Katarina Vajn; Ileana Lorenzini; Senka Majić; Won Ho Yang; Marija Heffer; Michael Tiemeyer; Jamey D Marth; Ronald L Schnaar
Journal:  Glycobiology       Date:  2012-06-26       Impact factor: 4.313

7.  Partial synthesis of ganglioside and lysoganglioside lipoforms as internal standards for MS quantification.

Authors:  Martin Gantner; Günter Schwarzmann; Konrad Sandhoff; Thomas Kolter
Journal:  J Lipid Res       Date:  2014-10-22       Impact factor: 5.922

8.  FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice.

Authors:  Guadalupe Vidal-Martinez; Katherine Najera; Julie D Miranda; Carolina Gil-Tommee; Barbara Yang; Javier Vargas-Medrano; Valeria Diaz-Pacheco; Ruth G Perez
Journal:  Neuroscience       Date:  2019-05-23       Impact factor: 3.590

9.  Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.

Authors:  Denggao Yao; Rhona McGonigal; Jennifer A Barrie; Joanna Cappell; Madeleine E Cunningham; Gavin R Meehan; Simon N Fewou; Julia M Edgar; Edward Rowan; Yuhsuke Ohmi; Keiko Furukawa; Koichi Furukawa; Peter J Brophy; Hugh J Willison
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  Expression of tyrosine kinase receptors in cultured dorsal root ganglion neurons in the presence of monosialoganglioside and skeletal muscle cells.

Authors:  Hao Li; Weiwei Zhang; Guixiang Liu; Jianmin Li; Huaxiang Liu; Zhenzhong Li
Journal:  J Muscle Res Cell Motil       Date:  2012-09-12       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.